Atlas Trials

Impact of Darbepoetin Alfa on Exercise Tolerance and Left Ventricular Structure in Subjects With Symptomatic Congestive Heart Failure (CHF) and Anemia

Clinical trial NCT00117234 · COMPLETED

Trial details

NCT number
NCT00117234
Sponsor
Amgen
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Congestive Heart FailureAnemia
Start date
2002-09-01

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.